US court lifts FDA ban of `natural' anticholesterol.

States a United States District Court in Utah lifted a ban on a product being sold as dietary supplement. The US Food and Drug Administration (FDA) contending Cholestin is an unapproved drug; The supplement, marketed by Pharmanex, containing a red-yeast rice; The issue of the product's fermentation process; Background on Pharmanex's lawsuit against the FDA.